Document is current
Any future updates will be listed below
-
Authors
Keller, Jacob https://orcid.org/0000-0001-6694-5507
Eglinsky, Jenny https://orcid.org/0009-0003-5417-7696
Garbade, Maike https://orcid.org/0000-0002-4585-7708
Pfeiffer, Elisa https://orcid.org/0000-0002-9742-3004
Plener, Paul L. https://orcid.org/0000-0003-4333-1494
Rosner, Rita https://orcid.org/0000-0002-7960-8398
Sukale, Thorsten
Sachser, Cedric https://orcid.org/0000-0002-9353-7936
-
Funding
Funding for this research was provided by:
Otto-Friedrich-Universität Bamberg
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 21 July 2025
First Online: 12 September 2025
Declarations
:
: The studies involving human participants were reviewed and approved by ethics committees at Ulm University (porta: No. 159/16) and Better Care (No. 243/19) and at the Catholic University of Eichstätt-Ingolstadt (Better Care: No. 004–19). If necessary, the participants and their legal guardians provided written informed consent to participate in this study.
: The authors declare no competing interests.
: PLP received research funding from Lundbeck and Servier. He received speaker honoraria from Janssen, infectopharm, GSK, Oral B and Medice.
